CSIMarket
 


Intelgenx Technologies Corp   (IGXT)
Other Ticker:  
 

Intelgenx Technologies 's Quick Ratio

IGXT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




IGXT Quick Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Change -25.95 % -48.29 % 91.11 % 81.68 % 218.57 %
Y / Y Cash & cash equivalent Change -49.99 % 38.6 % -64.3 % -49.75 % -49.41 %
Quick Ratio MRQ 0.38 0.61 0.33 0.75 0.56
Overall Ranking # # # # #
Seq. Current Liabilities Change 33.17 % -6.41 % 13.66 % -47.73 % -7 %
Seq. Cash & cash equivalent Change -17.58 % 73.09 % -50.4 % -29.31 % 128.4 %



Quick Ratio first quarter 2021 Comment
Due to increase in Current Liabilities in the first quarter 2021, Quick Ratio fell to 0.38 below Intelgenx Technologies Corp average.

Within Biotechnology & Pharmaceuticals industry 204 other companies have achieved higher Quick Ratio than Intelgenx Technologies in first quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are IGXT Segments?
See Quick Ratio IGXT on the trailing twelve month basis
Quick Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 205
Healthcare Sector # 798
Overall Market # 3172


Quick Ratio Statistics
High Average Low
9.2 2.81 0.23
(Mar 31 2012)   (Dec 31 2019)




Financial Statements
Intelgenx Technologies 's Current Liabilities $ 6 Millions Visit IGXT's Balance sheet
Intelgenx Technologies 's Cash & cash equivalent $ 2 Millions Visit IGXT's Balance sheet
Source of IGXT's Sales Visit IGXT's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2021, within Biotechnology & Pharmaceuticals Industry Quick RatioMar 31 2021 MRQ Cash & cash equivalentMar 31 2021 MRQ Current Liabilities
Fulgent Genetics Inc   1.01 $ 151.461  Millions$ 150.521  Millions
Amyris Inc   0.98 $ 143.821  Millions$ 147.110  Millions
Health Discovery Corporation  0.97 $ 0.731  Millions$ 0.753  Millions
Moderna Inc   0.92 $ 7,735.000  Millions$ 8,447.393  Millions
Acorda Therapeutics inc   0.88 $ 116.773  Millions$ 133.051  Millions
Portage Biotech Inc   0.86 $ 2.770  Millions$ 3.208  Millions
Agenus Inc  0.86 $ 119.366  Millions$ 138.374  Millions
Amgen Inc   0.82 $ 10,566.000  Millions$ 12,869.000  Millions
Cyanotech Corp  0.65 $ 3.767  Millions$ 5.808  Millions
Precipio inc   0.61 $ 2.286  Millions$ 3.760  Millions
Akoya Biosciences Inc   0.57 $ 11.691  Millions$ 20.558  Millions
Aytu Biopharma inc   0.56 $ 46.538  Millions$ 83.683  Millions
Regenerx Biopharmaceuticals inc   0.48 $ 0.208  Millions$ 0.432  Millions
Pactiv Evergreen Inc   0.45 $ 328.000  Millions$ 721.000  Millions
Biogen Inc   0.42 $ 1,320.000  Millions$ 3,165.800  Millions
Intelgenx Technologies Corp   0.38 $ 2.184  Millions$ 5.817  Millions
Cv Sciences Inc   0.36 $ 5.165  Millions$ 14.233  Millions
Axim Biotechnologies Inc   0.34 $ 0.449  Millions$ 1.314  Millions
Reynolds Consumer Products Inc   0.34 $ 144.000  Millions$ 424.000  Millions
Abbvie Inc   0.31 $ 9,777.000  Millions$ 31,951.000  Millions
Gilead Sciences Inc   0.25 $ 1,601.000  Millions$ 6,336.000  Millions
Protalix Biotherapeutics inc   0.25 $ 19.830  Millions$ 80.861  Millions
Inhibitor Therapeutics Inc   0.22 $ 0.084  Millions$ 0.381  Millions
Q Biomed inc   0.16 $ 0.435  Millions$ 2.649  Millions
Avantor Inc   0.14 $ 172.500  Millions$ 1,240.700  Millions
Gtx Corp  0.14 $ 0.413  Millions$ 2.981  Millions
Guided Therapeutics Inc  0.14 $ 1.247  Millions$ 9.229  Millions
Cytodyn inc   0.11 $ 14.291  Millions$ 128.861  Millions
Theralink Technologies Inc   0.11 $ 0.277  Millions$ 2.498  Millions
American Cryostem Corp  0.10 $ 0.123  Millions$ 1.198  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BUKS's Profile

Stock Price

BUKS's Financials

Business Description

Fundamentals

Charts & Quotes

BUKS's News

Suppliers

BUKS's Competitors

Customers & Markets

Economic Indicators

BUKS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071